Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia
    Published on 2024-08-31
    2 years ago
  • Replicability and generalizability in population psychiatric neuroimaging
    Published on 2024-08-30
    2 years ago
  • What can neuroimaging of neuromodulation reveal about the basis of circuit therapies for psychiatry?
    Published on 2024-08-28
    2 years ago
  • Acute sleep disruption reduces fear memories in male and female mice
    Published on 2024-08-28
    2 years ago
  • Prevalence and correlates of irritability among U.S. adults
    Published on 2024-08-24
    2 years ago
  • Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants
    Published on 2024-08-23
    2 years ago
  • Post-traumatic stress comorbidity in substance use disorder: machine learning analyses of phenotypic drivers
    Published on 2024-08-21
    2 years ago
« Previous 1 … 67 68 69 70 71 … 143 Next »
Journal of Psychopharmacology
  • Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers
    Published on 2022-11-15
    4 years ago
  • Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
    Published on 2022-11-15
    4 years ago
  • Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study
    Published on 2022-11-15
    4 years ago
  • Body mass index (BMI) does not predict responses to psilocybin
    Published on 2022-11-14
    4 years ago
  • Pharmacological characterization of 5-iodo-A-85380, a β2-selective nicotinic receptor agonist, in mice
    Published on 2022-11-02
    4 years ago
  • Association between quetiapine use and self-harm outcomes among people with recorded personality disorder in UK primary care: A self-controlled case series analysis
    Published on 2022-11-01
    4 years ago
  • Belief changes associated with psychedelic use
    Published on 2022-11-01
    4 years ago
« Previous 1 … 67 68 69 70 71 … 145 Next »
European Neuropsychopharmacology
  • Silexan for treatment of anxiety and depression in the context of COVID-19
    Published on 2023-02-24
    3 years ago
  • Defining cannabis risky use: Building the plane while you fly it
    Published on 2023-02-18
    3 years ago
  • Robotics in psychiatry – Fiction or reality?
    Published on 2023-02-16
    3 years ago
  • Premise, promise and challenges of MDMA assisted therapy for PTSD
    Published on 2023-02-16
    3 years ago
  • Improving drug development in precision psychiatry by ameliorating cognitive biases
    Published on 2023-02-15
    3 years ago
  • A shared decision journey to bridge the gap between treatment recommendation and low adherence?
    Published on 2023-02-13
    3 years ago
  • Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence
    Published on 2023-02-13
    3 years ago
« Previous 1 … 67 68 69 70 71 … 166 Next »

   Pharma Pub